Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Regeneron Pharmaceuticals Inc (REGN)

2014-10-21@14:44:32 ET
Stock Investors Bid Up Shares of Regeneron Pharmaceuticals, Up 2.5% (F77)

2014-10-21@10:02:59 ET
Regeneron Genetics announces new collaborations with academic institutions (DTM)

2014-10-21@06:01:52 ET
Quorum Review's Linda Coleman to Present at MAGI West 2014 (PRW)

2014-10-21@05:39:29 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-10-21@05:15:24 ET
Regeneron and Sanofi announce first-patient dosing in Phase III AD study (DTM)

2014-10-21@01:55:50 ET
Regeneron Earns Top Spot as Employer in the Global Biopharmaceutical Industry (CLM)

2014-10-20@11:50:04 ET
Regeneron Pharmaceuticals (REGN) Showing Bullish Technicals With Resistance At $384.37 (FBM)

2014-10-20@09:00:00 ET
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma (PRN)

2014-10-20@08:10:18 ET
Regeneron Pharmaceuticals is Among the Companies in the Biotechnology Industry with the Best Relative Performance (REGN, EBS, GILD, CPHD, INO) (F70)

2014-10-20@07:53:26 ET
Regeneron Pharmaceuticals begins Phase 3 clinical study of dupilumab in adults patients with moderate-to-severe atopic dermatitis (MTO)

2014-10-20@07:00:00 ET
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis (PRN)

2014-10-18@06:20:41 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-10-17@15:00:32 ET
Shares of Regeneron Pharmaceuticals Rise Above Previous 52-Week High (F71)

2014-10-17@14:40:10 ET
Friday's ETF Movers: BBH, GDX (MNV)

2014-10-17@14:39:09 ET
S&P 500 Analyst Moves: REGN (MNV)

2014-10-17@14:26:51 ET
Regeneron Pharmaceuticals Trading Higher on 2.3x Above-Average Volume (REGN) (F82)